Abstract PO4-04-12: A Phase 1b/2 study of palazestrant (OP-1250) in combination with ribociclib or alpelisib in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, advanced and/or metastatic breast cancer
Borges, Virginia, Alemany, Carlos, Lin, Nancy, Nunnery, Sara, Ma, Cynthia, Tonda, Margaret, Shaw, Morena, Chan, Arlene
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract P3-07-15: Preliminary data from a Phase 1b dose escalation study of OP-1250, an oral CERAN, in combination with palbociclib in patients with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer
Chan, Arlene, Day, Daphne, Hui, Rina, McCarthy, Nicole, Wilson, Rosalind, Faltaos, Demiana, Shaw, Morena, Murphy, Caitlin
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
B 및 T 림프구 약화인자 (BTLA) 조절제 및 이의 사용 방법
CORREIA JEAN DA SILVA, SHAW MORENA, DAHL MARTIN EDWARD, PARMLEY STEPHEN, KEHRY MARILYN
Year of Publication 29.06.2023
Get full text
Year of Publication 29.06.2023
Patent
Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: Structure-based drug design, synthesis, and biological evaluation
Vernier, William, Chong, Wesley, Rewolinski, David, Greasley, Samantha, Pauly, Thomas, Shaw, Morena, Dinh, Dac, Ferre, Rose Ann, Nukui, Seiji, Ornelas, Martha, Reyner, Eric
Published in Bioorganic & medicinal chemistry (01.05.2010)
Published in Bioorganic & medicinal chemistry (01.05.2010)
Get full text
Journal Article
Corrigendum to “Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: Structure-based drug design, synthesis, and biological evaluation” [Bioorg. Med. Chem. 18 (2010) 3307]
Vernier, William F., Chong, Wesley K.M., Rewolinski, David A., Greasley, Samantha E., Pauly, Thomas A., Shaw, Morena N., Dinh, Dac M., Ferre, Rose Ann A., Meador, James W., Nukui, Seiji, Ornelas, Martha A., Paz, Robert L., Reyner, Eric L.
Published in Bioorganic & medicinal chemistry (01.10.2010)
Published in Bioorganic & medicinal chemistry (01.10.2010)
Get full text
Journal Article
B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME
Kehry, Marilyn, Shaw, Morena, Correia, Jean da Silva, Dahl, Martin Edward, Parmley, Stephen
Year of Publication 07.12.2023
Get full text
Year of Publication 07.12.2023
Patent
B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME
DAHL, Martin Edward, PARMLEY, Stephen, CORREIA, Jean da Silva, SHAW, Morena, KEHRY, Marilyn
Year of Publication 30.08.2023
Get full text
Year of Publication 30.08.2023
Patent
B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME
DAHL, Martin Edward, PARMLEY, Stephen, CORREIA, Jean da Silva, SHAW, Morena, KEHRY, Marilyn
Year of Publication 08.06.2023
Get full text
Year of Publication 08.06.2023
Patent
B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME
DAHL, Martin Edward, PARMLEY, Stephen, CORREIA, Jean da Silva, SHAW, Morena, KEHRY, Marilyn
Year of Publication 25.08.2022
Get full text
Year of Publication 25.08.2022
Patent
B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME
DAHL, Martin Edward, PARMLEY, Stephen, CORREIA, Jean da Silva, SHAW, Morena, KEHRY, Marilyn
Year of Publication 28.04.2022
Get full text
Year of Publication 28.04.2022
Patent
B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME
KEHRY, MARILYN, SHAW, MORENA, CORREIA, JEAN DA SILVA, PARMLEY, STEPHEN, DAHL, MARTIN EDWARD
Year of Publication 28.04.2022
Get full text
Year of Publication 28.04.2022
Patent
B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME
DAHL Martin Edward, SHAW Morena, PARMLEY Stephen, KEHRY Marilyn, CORREIA Jean Da Silva
Year of Publication 12.05.2023
Get full text
Year of Publication 12.05.2023
Patent